Active, Not Recruiting
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
NCT05195632
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
- Beijing Chest Hospital, Capital Medical University Beijing, China
- Peking University First Hospital Beijing, China
- The First Hospital of Jilin University Changchun, China